Hold-rated reports

904 tickers rated Hold
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Mercury General Corporation
MCY·Financials
B ★★★Hold
Current$84.48
Target$97.20
Return+15.1%
Nov 6, 2026

Mercury General offers profitable insurance underwriting, improving capital strength, and attractive relative valuation, but concentrated California catastrophe exposure and volatile investment results limit confidence in sustained earnings growth.

Score
74
Fortune Brands Innovations, Inc.
FBIN·Industrials
B ★★★Hold
Current$47.04
Target$51.20
Return+8.8%
Nov 6, 2026

Fortune Brands offers a branded building-products recovery opportunity supported by restructuring and cash generation, but weak housing demand and uncertain margin normalization may delay shareholder value creation.

Score
74
Duolingo, Inc.
DUOL·Technology
B ★★★Hold
Current$157.02
Target$176.97
Return+12.7%
Nov 6, 2026

Duolingo combines a leading global learning platform, accelerating user engagement, and strong recurring cash flow, but premium operating-earnings valuation and uncertain subscriber monetization constrain near-term upside.

Score
74
Fidelity National Information Services, Inc.
FIS·Technology
B ★★★Hold
Current$29.39
Target$42.40
Return+44.3%
Nov 6, 2026

FIS offers deeply discounted, cash-generative financial technology infrastructure with substantial switching costs, but elevated acquisition debt, slowing organic growth, and weakened management credibility threaten the recovery.

Score
74
BBB Foods Inc.
TBBB·Consumer Staples
B ★★★Hold
Current$65.07
Target$69.73
Return+7.2%
Nov 5, 2026

BBB Foods can compound revenue through rapid Mexican hard-discount expansion and improving store economics, but its premium valuation and thin retail margins leave limited protection against slower growth or weaker cash conversion.

Score
74
Jazz Pharmaceuticals plc
JAZZ·Healthcare
B ★★★Hold
Current$234.66
Target$256.56
Return+9.3%
Nov 5, 2026

Jazz Pharmaceuticals combines strong specialty-drug cash flows with expanding oncology growth opportunities, but acquisition execution, generic competition, and the stock's valuation recovery limit its near-term margin of safety.

Score
74
Miami International Holdings, Inc.
MIAX·Financials
B ★★★Hold
Current$34.67
Target$42.00
Return+21.1%
Nov 2, 2026

Miami International Holdings offers scalable exchange infrastructure, rising options profitability, and substantial liquidity, but concentrated trading-volume exposure, competitive pricing, and unproven futures investments constrain the margin of safety.

Score
74
Healthcare Realty Trust Incorporated
HR·Real Estate
B ★★★Hold
Current$18.49
Target$20.64
Return+11.6%
Nov 2, 2026

Healthcare Realty offers attractive REIT income and improving medical outpatient property cash flows, but elevated leverage and portfolio restructuring limit the certainty of sustained per-share earnings growth.

Score
74
Eastman Chemical Company
EMN·Materials
B ★★★Hold
Current$66.53
Target$76.80
Return+15.4%
Nov 2, 2026

Eastman's discounted specialty-materials portfolio and circular-recycling growth opportunity offer recovery potential, but elevated leverage, uneven cash conversion, and cyclical industrial demand constrain the near-term investment case.

Score
74
Intapp, Inc.
INTA·Technology
B ★★★Hold
Current$42.21
Target$43.16
Return+2.3%
Nov 2, 2026

Intapp combines high-retention vertical SaaS, accelerating cloud adoption, and improving operating leverage, but its valuation and substantial equity compensation leave limited room for execution setbacks.

Score
74
Arthur J. Gallagher & Co.
AJG·Financials
B ★★★Hold
Current$276.07
Target$300.00
Return+8.7%
Nov 1, 2026

Gallagher combines durable insurance brokerage relationships, recurring commissions and acquisition synergies, but substantial debt and demanding cash-flow growth expectations constrain the margin of safety.

Score
74